Evidence mapPaperPMID 37447326Full record

SynthesisNutrients2023

Awareness and Use of Low-Sodium Salt Substitutes and Its Impact on 24-h Urinary Sodium and Potassium Excretion in China-A Cross-Sectional Study.

Puhong Zhang, Fang Fan, Yinghua Li, Yuan Li, Rong Luo, Li Li, Gang Zhang, Lanlan Wang, Xiaofei Jiao, Feng J He

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Puhong ZhangThe George Institute for Global Health, Beijing 100600, China.ORCID 0000-0003-4610-9848
Fang FanSchool of Public Health, Anhui Medical University, Hefei 230032, China.
Yinghua LiChinese Center for Health Education, Beijing 100011, China.
Yuan LiThe George Institute for Global Health, Beijing 100600, China.ORCID 0000-0003-1887-7065
Rong LuoThe George Institute for Global Health, Beijing 100600, China.
Li LiChinese Center for Health Education, Beijing 100011, China.
Gang ZhangChinese Center for Health Education, Beijing 100011, China.
Lanlan WangChinese Center for Health Education, Beijing 100011, China.
Xiaofei JiaoChinese Center for Health Education, Beijing 100011, China.
Feng J HeWolfson Institute of Population Health, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London E1 4NS, UK.ORCID 0000-0003-2807-4119
UNSW Sydney · AUQueen Mary University of London · GBAnhui Medical University · CNGeorge Institute for Global Health · CN

Funding

National Institute for Health Research 16/136/77
6 · The paper itself

Abstract

The use of low-sodium salt substitute (LSSS) has the potential to reduce sodium and increase potassium intake. LSSS has been available in the Chinese market for years. However, its real-world use and impact on sodium/potassium intake is unclear. Baseline data of 4000 adult individuals who participated in three similarly designed randomized controlled trials were pooled together for this analysis. Self-reported awareness and use of LSSS were collected using a standardized questionnaire, and the participants' 24-h urinary sodium and potassium excretion was used to estimate their dietary intake. Mixed-effects models were developed to assess the relationship between LSSS and 24-h urinary sodium and potassium excretion. 32.0% of the participants reported awareness of LSSS and 11.7% reported its current use. After adjusting for location, sex, age, and education, compared with the group of participants unaware of LSSS, participants who were aware of but not using LSSS and those who were using LSSS had a lower 24-h urinary sodium excretion by -356.1 (95% CI: -503.9, -205.9) mg/d and -490.6 (95% CI: -679.2, -293.7) mg/d, respectively (

Indexed as

HypertensionSodium, DietaryAdultCross-Sectional StudiesDiet, Sodium-RestrictedHumansPotassiumRandomized Controlled Trials as TopicSodiumSodium Chloride, DietarySodium RadioisotopesPotassiumSodiumSodium-24Sodium Chloride, DietarySodium, DietarySodium Radioisotopes24-h urinary potassium excretion24-h urinary sodium excretionlow-sodium salt substitutes (LSSS)sodium-to-potassium ratio

Identifiers

PMID37447326
PMCPMC10346169
OpenAlexW4382981423

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.